Ocugen Inc. Announces Nirdosh Jagota, Ph.D. as Senior Vice President, Regulatory Affairs, Compliance & Safety
January 24, 2022 07:12 ET | Ocugen
MALVERN, Pa., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Gilat Satellite Networks Logo
Gilat and Intelsat Expand Their Strategic Partnership in Commercial Aviation
January 24, 2022 07:04 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Verizon Communications to report earnings January 25, 2022
January 24, 2022 07:00 ET | Verizon Sourcing LLC
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report fourth-quarter 2021 earnings on Tuesday, January 25. The company will present results on a...
Tango Logo.png
Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
January 24, 2022 07:00 ET | Tango Therapeutics, Inc.
- TNG908 IND cleared by FDA, Phase 1/2 trial expected to start in 1H 2022 - Additional pipeline programs progressing throughout 2022 CAMBRIDGE, Mass., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tango...
Southern States Bancshares, Inc. Announces Fourth Quarter 2021 Financial Results
January 24, 2022 07:00 ET | Southern States Bancshares, Inc
Fourth Quarter 2021 Highlights Linked quarter loan growth was 36.3% annualized, or 40.9% annualized, excluding the impact of Paycheck Protection Program (PPP) loansNet income of $4.1 million, or...
Connect Biopharma Presents Data and Analyses from the Global Phase 2b Trial of CBP-201 at the Maui Derm Conference
January 24, 2022 07:00 ET | Connect Biopharma Holdings Limited
—Data provides detailed results, with achievement of both primary and key secondary end points and demonstrating significant improvements in skin clearance, disease severity, and itch compared to...
HCW Logo_Full_Color_600x_JPEG (2).jpg
Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics’ Novel Bifunctional Fusion Protein
January 24, 2022 07:00 ET | HCW Biologics, Inc
MIRAMAR, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to...
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies
January 24, 2022 07:00 ET | TScan Therapeutics, Inc.
– Phase 1 trial of TSC-100 expected to initiate in the first half of 2022 – – IND for TSC-101 on hold pending additional assessment of the risk of off-tumor reactivity – WALTHAM, Mass., Jan. ...
Colliers to invest in leading infrastructure investment firm
January 24, 2022 07:00 ET | Colliers International Group Inc.
TORONTO and LONDON and NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Leading diversified professional services and investment management company, Colliers (NASDAQ and TSX: CIGI), announced today it...
Diversey Strengthens Presence in Europe with Accretive Acquisition of Shorrock Trichem
January 24, 2022 07:00 ET | Diversey, Inc.
Acquisition Highlights: Strengthens leading market position in the UK.Expands portfolio of products and services, including innovative sustainability solutions.Enhances Diversey’s sales and service...